February 14th 2025
Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Advocate Discusses Her Family's History With Hidradenitis Suppurativa
July 30th 2022The journey to a diagnosis of hidradenitis suppurativa was different for her compared with the path faced by her children, said Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected with the disease.
Watch
Overuse of Systemic Corticosteroids, Substantial Cost Burden for AD Seen in Germany
July 29th 2022Systemic corticosteroids were more commonly prescribed vs other systemic drug options in Germany for patients with atopic dermatitis (AD) despite their unfavorable risk-benefit profile, with a substantial economic burden cited among these populations.
Read More
Registries Highlight the Needs of Patients With COPD in Primary Care
July 28th 2022US patients with chronic obstructive pulmonary disease (COPD) managed in primary care settings have high exacerbations, symptoms, and treatment burdens, according to an analysis of electronic health record data and patient-reported information/outcomes.
Read More
Senator Joe Manchin, D-West Virginia, ended his opposition to the Inflation Reduction Act of 2022, paving the way for reductions in some Affordable Care Act subsidies and action on drug pricing; AbbVie’s Allergan agreed to pay more than $2 billion in opioid settlements; a study found vitamin D supplements do not reduce bone fracture risk.
Read More
Bacteria Behind Rare Disease Melioidosis Found in US for First Time
July 27th 2022For the first time, the CDC has identified in Mississippi dirt and water samples a bacteria that causes a rare and sometimes fatal disease called melioidosis, which is common in low-income tropical countries and one that scientists have been warning about for several years.
Read More
US Monkeypox Cases Number Nearly 3600 as HHS Approves Additional Vaccine
July 27th 2022The number of monkeypox cases in the United States is close to 3600, the CDC said this week, and on Wednesday, HHS approved a supplement to the biologics license for a vaccine made by Bavarian Nordic to prevent smallpox and monkeypox.
Read More
Contributor: How Medication Risk Scores Improve Health for Medicare Beneficiaries
July 27th 2022Medication risk scores analyze an individual’s medication regimen to look for the potential for simultaneous, multi-drug interactions, which can cause adverse drug events and other medication-related harms.
Read More
Risk of Myocardial Infarction Greater Among Patients With Hidradenitis Suppurativa
July 25th 2022An increased risk of developing myocardial infarction was observed among patients with hidradenitis suppurativa (HS), whereas risk of cerebrovascular accident and peripheral vascular disease was comparable between those with HS and controls.
Read More
The World Health Organization declared monkeypox a global health emergency; Sen. Amy Klobuchar, D-Minnesota, calls for Federal Trade Commission to look into Amazon’s acquisition of One Medical; a Tuesday White House summit will include experts to discuss the development of updated COVID-19 vaccines.
Read More
Dr Patrick Burnett Discusses Risk Factors for Adverse Behavioral Health, QOL in Psoriasis
July 23rd 2022Patrick Burnett, MD, PhD, FAAD, chief medical officer of Arcutis Biotherapeutics, discussed key factors associated with poor behavioral health issues and quality of life among patients with psoriasis.
Watch
Dr Elaine Siegfried Discusses Step Edits, Barriers to AD Treatment
July 23rd 2022Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, speaks on step edits and other barriers limiting access to biologic, topical, and other medications for the treatment of atopic dermatitis (AD).
Watch
Omnipod 5 May Improve Psychosocial Outcomes for Patients With T1D, Study Suggests
July 21st 2022Patients with type 1 diabetes (T1D) who used the Omnipod 5 Automated Insulin Delivery (AID) System saw significant improvements in psychosocial outcomes, including diabetes distress and hypoglycemic confidence over a 3-month period.
Read More
Horizon Model Makes Behavioral Health the "Quarterback" in Chronic Care Management
July 20th 2022Stakeholders from Horizon Blue Cross Blue Shield of New Jersey discuss new ways to address management gaps for chronic behavioral health conditions, including a new integrated care model that puts community behavioral health providers in charge of overall care.
Read More
Integrated Primary Care Effective for Patients With Severe COPD With No Increase in Costs
July 19th 2022An integrated primary care service may improve the health status of patients with severe chronic obstructive pulmonary disease (COPD) without increasing health care costs, according to a recent study.
Read More
Diabetes Prevention Programs Go Unused Even as Prediabetes Soars
July 13th 2022Although prediabetes prevalence jumped 4.8 percentage points from 2010 to 2020, barriers to accessing diabetes prevention interventions persist, driven by cost, eligibility requirements, and data integration, leading to low participation rates.
Read More
Disinfectant Linked With Reduced Hospital-Onset Clostridioides difficile Infection
July 13th 2022Hospital ward cleaning with potassium peroxymonosulphate-based environmental disinfectant and a decrease in days of therapy with carbapenems were associated with a reduction in the rate of hospital-onset Clostridioides difficile infection.
Read More
Stakeholders List 6 Actionable Steps to Ameliorate Global Disparities in Parkinson Disease
July 11th 2022Advocacy and awareness; prevention and risk reduction; diagnosis, treatment, and care; caregiver support; and research were listed as actionable steps that are urgently needed to address global disparities in Parkinson disease.
Read More
Certain Factors May Reduce ESS-Induced Smell Improvement in CRSwNP
July 9th 2022Endoscopic sinus surgery was associated with improvement in self-reported olfactory function among patients with chronic rhinosinusitis with nasal polyps (CRSwNP), in which a longer CRSwNP disease course and higher blood eosinophilia were cited as risk factors linked with poor sense of smell recovery.
Read More